Clinical judgment, not AI hype.
TheraIntel is shorthand for therapeutic intelligence: clinical judgment brought to the AI reshaping pharmacy and care. It is an independent publication of news and analysis on AI in pharmacy, telepharmacy, and clinical operations, written for the people who run the work.
Why it exists
The healthcare AI conversation is loud, and most of it is written by people who have never verified an order or run a pharmacist schedule. TheraIntel is the operator's read: what the technology actually does, what the regulation actually says, and what it means for the people doing the work. No vendor pitch, no hype, every material claim linked to its source.
What it covers
Four beats: telepharmacy, AI strategy, clinical AI, and AI regulation. Telepharmacy looks at remote verification, workforce capacity, and pharmacist accountability. AI strategy covers implementation, ROI, governance, and the operating-model changes behind the tools that actually ship. Clinical AI tracks decision support, automation bias, and clinician deskilling at the point of care. AI regulation follows the FDA, CMS, OIG, and state pharmacy law, and what their moves mean for operators.
Who writes it
Shan Siddique is a practicing clinical pharmacist with over a decade of frontline healthcare operations experience, including lead pharmacist work in a national telepharmacy organization. That operational vantage is the point: the analysis here is grounded in how verification queues, staffing, compliance, and clinical workflows actually behave, not in how a product demo says they should.
Independence
TheraIntel is independent. The analysis is editorial, written on personal time, and the views expressed are the author's own. They do not represent any employer, and no confidential or proprietary operational data is used. Any relevant financial or vendor relationship is disclosed where it applies.
For how sources are selected, how corrections are handled, and the full disclosure policy, see the editorial standards.